Aileron Therapeutics
Stock Forecast, Prediction & Price Target
Aileron Therapeutics Financial Estimates
Aileron Therapeutics Revenue Estimates
Aileron Therapeutics EBITDA Estimates
Aileron Therapeutics Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $69.75M Low: $69.75M High: $69.75M avg. 0% | Avg: $127.66M Low: $127.66M High: $127.66M avg. 83.00% | |
Net Income
% change YoY
| $-25.76M N/A | $-27.01M -4.84% | $-15.73M 41.75% | Avg: $-23.98M Low: $-8.32M High: $-4.46M avg. -52.43% | Avg: $-25.68M Low: $-5.79M High: $-5.79M avg. -7.10% | Avg: $-4.82M Low: $-4.82M High: $-4.82M avg. 81.20% | |
EBITDA
% change YoY
| $-26.88M N/A | $-27.47M -2.20% | $-15.61M 43.17% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | |
EPS
% change YoY
| -$5.8 N/A | -$5.95 -2.58% | -$3.42 42.52% | Avg: -$1.39 Low: -$1.81 High: -$0.97 avg. 59.35% | Avg: -$1.26 Low: -$1.26 High: -$1.26 avg. 9.35% | Avg: -$1.05 Low: -$1.05 High: -$1.05 avg. 16.66% | |
Operating Expenses
% change YoY
| $26.60M N/A | $27.64M 3.91% | $16.27M -41.12% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Aileron Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 7.22% in 2025-2027.
We have gathered data from 1 analysts. Their low estimate is -8.32M, average is -23.98M and high is -4.46M.
What is Aileron Therapeutics stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 27.66% in 2025-2027.
We have gathered data from 2 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Aileron Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 28.45% in 2025-2027.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$1.81, average is -$1.39 and high is $-0.97.